Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Cara Therapeutics Inc. logo

Cara Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

0.70
 
USD
  
0.03
  
(4.23%)
Optionable: Yes  Market Cap: 39 M  90-day average vol: 636,541

Previous close: 0.6716  Open: 0.661  Bid: 0.6603  Ask: 0.7168
52 week range    
0.50   
   4.67
Peers   
TRVN / 
REPH / 
ACRX / 
PFE / 
JNJ / 
CPIX / 
ACOR / 
Last updated: Friday 26th April 2024
44
MarketXLS Rank
60
Value
23
Technical
50
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

CARA Cash Flow

Annual
Invalid dateDec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
(Increase) Decrease in inventories-3 M201000.0
(Increase) Decrease in other current liabilities-2 M-1 M42 M-20 M-22 M
(Increase) Decrease in payables-12000.03 M6 M-3 M5 M6 M-3 M-1 M6 M
(Increase) Decrease in receivables-139000.0-264000.0-475000.085000.0-736000.0-197000.0-277000.0912000.0-3 M
Amortization of intangibles601000.0806000.01 M1 M
CapitalExpenditureReported42000.020000.0717000.058000.073000.018000.0349000.039000.043000.0
Cash at beginning of period12 M53 M15 M14 M10 M16 M19 M32 M14 M
Cash at end of period53 M90 M12 M10 M16 M19 M32 M14 M64 M
Cash flow-18 M-21 M-47 M-55 M-22 M-109 M-5 M-60 M-79 M
CashFlowFromContinuingInvestingActivities-42000.0-92 M44 M-36 M-83 M-31 M-20 M-5 M129 M
ChangeInAccountPayable-12000.03 M6 M-3 M5 M6 M-3 M-1 M6 M
ChangeInPayablesAndAccruedExpense-12000.03 M6 M-3 M5 M6 M-3 M-1 M6 M
ChangeInPrepaidAssets388000.0-1 M199000.0-105000.0-3 M-4 M-3 M10 M-14 M
ChangeInWorkingCapital-2 M164000.06 M-3 M43 M-18 M-29 M7 M-13 M
ChangesInAccountReceivables-3 M
Depreciation783000.0839000.01 M495000.0370000.0198000.0209000.0248000.0248000.0
Depreciation unreconciled783000.0821000.01 M-87000.0-1 M-582000.01 M2 M128000.0
DepreciationAndAmortization783000.0821000.01 M-87000.0-1 M-582000.01 M2 M128000.0
FinancingCashFlow58 M151 M123000.088 M111 M143 M39 M47 M311000.0
Free cash flow-18 M-21 M-48 M-55 M-22 M-109 M-6 M-60 M-79 M
GainLossOnInvestmentSecurities-5000.05000.0-272000.0-39000.0
GainLossOnSaleOfPPE2000.0-41000.0-70000.0
Issuance of capital stock58 M150 M86 M92 M136 M
IssuanceOfCapitalStock58 M150 M86 M92 M136 M
Net cash from financing activities58 M151 M123000.088 M111 M143 M39 M47 M311000.0
Net cash from investing activities-42000.0-92 M44 M-36 M-83 M-31 M-20 M-5 M129 M
Net cash from operating activities-18 M-21 M-47 M-55 M-22 M-109 M-5 M-60 M-79 M
Net change in cash & cash equivalents40 M38 M-3 M-3 M6 M3 M13 M-18 M50 M
Net income from continuing operations-18 M-25 M-57 M-58 M-74 M-106 M8 M-88 M-85 M
NetCommonStockIssuance58 M150 M86 M92 M136 M
NetInvestmentPropertiesPurchaseAndSale-92 M45 M-36 M-83 M-30 M-20 M-5 M129 M
NetInvestmentPurchaseAndSale-92 M45 M-36 M-83 M-30 M-20 M-5 M129 M
NetPPEPurchaseAndSale-42000.0-20000.0-717000.0-17000.0-73000.0-18000.0-349000.031000.0-43000.0
Operating (gains) losses2000.0-23000.0-46000.05000.0-272000.0-109000.0
Other financing charges net58 M15 M38 M45 M
Other investing changes net-769000.0700000.02 M27 M21 M4 M
Other non-cash items1 M2 M3 M6 M10 M16 M14 M19 M1 M
ProceedsFromStockOptionExercised128000.0362000.0123000.02 M4 M6 M691000.02 M311000.0
Purchase of Float term investments-92 M-69 M-127 M-338 M-286 M-233 M-209 M-96 M
Purchase of property plant & equipment-42000.0-20000.0-717000.0-17000.0-73000.0-18000.0-349000.031000.0-43000.0
PurchaseOfInvestment-92 M-69 M-127 M-338 M-286 M-233 M-209 M-96 M
PurchaseOfPPE-42000.0-20000.0-717000.0-58000.0-73000.0-18000.0-349000.0-39000.0-43000.0
Revenue per share-18000.0-218000.0-582000.0-2 M-780000.0960000.02 M2 M
Sale of short term investments114 M91 M255 M254 M186 M184 M220 M
SaleOfInvestment114 M91 M255 M254 M186 M184 M224 M
SaleOfPPE41000.070000.0
StockBasedCompensation1 M3 M3 M6 M9 M13 M15 M21 M18 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University